Effect of α-tocopherol and β-carotene supplementation on coronary heart disease during the 6-year post-trial follow-up in the ATBC study

European Heart Journal

Volumn 25, Issue 13, 2004, Pages 1171-1178

  Törnwall, Markareetta E ^a   Virtamo, Jarmo ^a   Korhonen, Pasi A ^a   Virtanen, Mikko J ^a   Taylor, Philip R ^b   Albanes, Demetrius ^b   Huttunen, Jussi K ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Tocopherol; Carotene; Coronary heart disease; Supplementation

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; PLACEBO;

ADULT; AGED; ARTICLE; CANCER PREVENTION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FATALITY; FOLLOW UP; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SMOKING;

AGED; ALPHA-TOCOPHEROL; ANTIOXIDANTS; BETA CAROTENE; CORONARY DISEASE; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; SMOKING; SURVIVAL ANALYSIS;

EID: 3042621001     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2004.05.007     Document Type: Article

References (33)

1. Esterbauer H., Rotheneder M., Striegl G., et al. Vitamin E and other lipophilic antioxidants protect LDL against oxidation. Fat. Sci. Technol. 91:1989;316-324
2. Kaplan M., Aviram M. Oxidized low density lipoprotein: atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role of nutritional antioxidants and serum paraoxonase. Clin. Chem. Lab. Med. 37:1999;777-787
3. Böhm F., Edge R., Land E.J., et al. Carotenoids enhance vitamin E antioxidant efficiency. J. Am. Chem. Soc. 119:1997;621-622
4. Smith I., Franks P.J., Greenhalgh R.M., et al. The influence of smoking cessation and hypertriglyseridaemia on the progression of peripheral arterial disease and the onset of critical ischaemia. Eur. J. Vasc. Endovasc. Surg. 11:1996;402-408
5. Rimm E.B., Stampfer M.J., Ascherio A., et al. Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med. 328:1993;1450-1456
6. Knekt P., Reunanen A., Järvinen R., et al. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am. J. Epidemiol. 139:1994;1180-1189
7. Kushi L.H., Folsom A.R., Prineas R.J., et al. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N. Engl. J. Med. 334:1996;1156-1162
8. Klipstein-Grobusch K., Geleijnse J.M., den Breeijen J.H., et al. Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study. Am. J. Clin. Nutr. 69:1999;261-266
9. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35
10. Virtamo J., Rapola J.M., Ripatti S., et al. Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. Arch. Intern. Med. 158:1998;668-675
11. Hennekens C.H., Buring J.E., Manson J.E., et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N. Engl. J. Med. 334:1996;1145-1149
12. Omenn G.S., Goodman G.E., Thornquist M.D., et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med. 334:1996;1150-1155
13. The Heart Outcomes Prevention Evaluation Study Investigators. Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 2000;342:154-60
14. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999;354:447-55
15. Rapola J.M., Virtamo J., Ripatti S., et al. Randomised trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet. 349:1997;1715-1720
16. Stephens N.G., Parsons A., Schofield P.M., et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 347:1996;781-786
17. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:23-33
18. The ATBC Cancer Prevention Study Group. The Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study: design, methods, participant characteristics, and compliance. Ann Epidemiol 1994;4:1-10
19. Rose G.A. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull. World Health Organ. 27:1962;645-658
20. Rapola J.M., Virtamo J., Korhonen P., et al. Validity of diagnoses of major coronary events in national registers of hospital diagnoses and deaths in Finland. Eur. J. Epidemiol. 13:1997;133-138
21. Breslow N.E., Day N.E. Statistical methods in cancer research. vol. II:1987;IARC, Lyon
22. Hastie T.J., Tibshirani R.J. Generalized additive models. 1990;Chapman & Hall
23. Collaborative Group of the Primary Prevention Project (PPP). Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet 2001;357:89-95
24. Vivekananthan D.P., Penn M.S., Sapp S.K., et al. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet. 361:2003;2017-2023
25. Hercberg S., Galan P., Preziosi P., et al. Background and rationale behind the SU.VI.MAX. Study, a prevention trial using nutritional doses of a combination of antioxidant vitamins and minerals to reduce cardiovascular diseases and cancers. Int. J. Vitam. Nutr. Res. 68:1998;3-20
26. Manson J.E., Gaziano J.M., Spelsberg A., et al. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Ann. Epidemiol. 5:1995;261-269
27. Rexrode K.M., Lee I.M., Cook N.R., et al. Baseline characteristics of participants in the Women's Health Study. J. Womens Health Gend. Based Med. 9:2000;19-27
28. Christen W.G., Gaziano J.M., Hennekens C.H. Design of Physicians' Health Study II - A randomized trial of β-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Ann. Epidemiol. 10:2000;125-134
29. Pandey D.K., Shekelle R., Selwyn B.J., et al. Dietary vitamin C and β-carotene and risk of death in middle-aged men. The Western Electric Study. Am. J. Epidemiol. 142:1995;1269-1278
30. Lee I.M., Cook N.R., Manson J.E., et al. β-Carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study. J. Natl. Cancer Inst. 91:1999;2102-2106
31. Truscott T.G. β-Carotene and disease: a suggested pro-oxidant and anti-oxidant mechanism and speculations concerning its role in cigarette smoking. J. Photochem. Photobiol. B. 35:1996;233-235
32. Prince M.R., LaMuraglia G.M., MacNichol E.F. Jr. Increased preferential absorption in human atherosclerotic plaque with oral beta carotene. Implications for laser endarterectomy. Circulation. 78:1988;338-344
33. Mitchell D.C., Prince M.R., Frisoli J.K., et al. Beta carotene uptake into atherosclerotic plaque: enhanced staining and preferential ablation with the pulsed dye laser. Lasers Surg. Med. 13:1993;149-157